AllStripes is a Public Benefit Corporation dedicated to unlocking new treatments for people affected by rare diseases. Inspired by the zebra, the symbol of the rare disease community, we believe that by coming together and learning from each other's experiences, we can advocate for better treatments across all rare conditions. Founded in 2017 by CEO Nancy Yu and rare disease patient Onno Faber, AllStripes is the leading research platform specifically focused on rare diseases.

Our mission is personal, driven by our own experiences and the desire to make a difference. We make it easy for patients to contribute to new treatment research from the comfort of their homes. We collect and analyze de-identified medical records to power faster and better drug development.

By partnering with rare disease patient advocacy organizations, key opinion leaders, academic institutions, and pharmaceutical companies, we aim to make progress towards new treatments. Our expert researchers produce original insights and publications, driving innovation in the field. Join the AllStripes team and help transform treatment research for rare diseases.

Together, we can make a difference and improve the lives of those affected